Tanaka, Shinji
Saitoh, Yusuke
Matsuda, Takahisa
Igarashi, Masahiro
Matsumoto, Takayuki
Iwao, Yasushi
Suzuki, Yasumoto
Nozaki, Ryoichi
Sugai, Tamotsu
Oka, Shiro
Itabashi, Michio
Sugihara, Ken-ichi
Tsuruta, Osamu
Hirata, Ichiro
Nishida, Hiroshi
Miwa, Hiroto
Enomoto, Nobuyuki
Shimosegawa, Tooru
Koike, Kazuhiko
Article History
Received: 14 December 2020
Accepted: 27 February 2021
First Online: 12 March 2021
Declarations
:
: Any financial relationship with enterprises, businesses or academic institutions in the subject matter or materials discussed in the manuscript are listed as follows; (1) those from which the authors, the spouse, partner or immediate relatives of authors, have received individually any income, honoraria or any other types of remuneration; Olympus Corporation, Astellas Pharmaceutical, Taiho Pharmaceutical, Takeda Pharmaceutical, Chugai Pharmaceutical, Pfizer, and (2) those from which the academic institutions of the authors received support (commercial/academic cooperation); Taiho Pharmaceutical, Tsumura & Co., Bristol Myers Squibb, Astellas Pharmaceutical, Abbvie, EA Pharma, Eisai, MSD, Ono Pharmaceutical, CSL Behring, Johnson & Johnson, Mochida Pharmaceutical, Taiho Pharmaceutical, Takeda Pharmaceutical, Chugai Pharmaceutical, Eli Lilly Japan, Japan Blood Products Organization, Novartis Pharma, Bayer Japan, Merck Biopharma, Asahi Kasei Pharma.